NDC product
Mucus Relief Congestion and Cough Maximum Strength
NDC 11673-337 · TARGET Corporation
Key facts
| Product NDC | 11673-337 |
|---|---|
| Proprietary name | Mucus Relief Congestion and Cough |
| Nonproprietary name | Dextromethorphan HBr, Guaifenesin, Phenylephrine HCI |
| Substances | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE |
| Dosage form | LIQUID |
| Route | ORAL |
| Labeler | TARGET Corporation |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA] and 3 more |
| Marketing start | Jul 31, 2016 |
| Marketing end | Jun 28, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory